Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TRANSITION THERAPEUTICS INC. T.TTH

"Transition Therapeutics Inc is a product-focused biopharmaceutical company. The Company is engaged in developing therapeutics for disease indications with markets. Its technologies are focused on the treatment of Alzheimer's disease and diabetes."


TSX:TTH - Post by User

Comment by deninsaskon Mar 05, 2007 12:44pm
442 Views
Post# 12356789

RE: Confrence Call........Congrats Longs

RE: Confrence Call........Congrats Longs Thanks whocares............ ......"He also said the board felt it would warrant them to continue development, and not sit on there hands waiting for Novo to decide. He did reiterate the results had even exceeded there expectations." I guess not Man!! Some of the greatest minds in the diabetes world sit on that scientific board. He's learned from experience to move forward without Novo is a good thing if need be..........can Novo decide to option In and still let Transition go ahead and run the Phasellb ? Probably.......so that decision is Very Bullish. Like many others on this BB and throughout the TTH Shareholder universe, I'm very relieved the news is finally out and positive and perhaps our little smallcap can now keep to their timelines........LOL As doug loe said last report that neither a negative or positive result for E1-INT will affect his Target of $3 so I don't expect an update from him soon to evaluate the E1-INT results effect on his valuations. Watch for the AZD-103 table pounding to begin in earnest.........!!
Bullboard Posts